// App-Quantinova.ai

1029 : HepFree: A large cluster randomised controlled cross sectional trial to assess screening and treating first and second generation migrants from ‘At Risk’ countries with chronic viral hepatitis

Researchers

Presenter

  • Stuart Flanagan

Principal Investigators

  • Victoria J. Appleby

  • Jessica Gaviria

  • Vichithranie Madurasinghe

  • Jan Kunkel

  • Sandra Eldridge

  • Sulleman Moreea

  • Kosh Agarwal

  • Graham R. Foster

Medical Centers

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Bradford Institute for Health Research, Bradford, United Kingdom

  • Department of Oncology, King's College Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved